Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
TNGX compared with PTGX: revenue, margins and what each company keeps, and the suppliers and customers both name
TNGX
Tango Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
PTGX
Protagonist Therapeutics, Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
TNGX
Tango Therapeutics, Inc.
vs
PTGX
Protagonist Therapeutics, Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
TNGX
Tango Therapeutics, Inc.
Change
22.72
· pre 22.72
· delayed
Mkt cap
$3.8B
Revenue
$54M
Q3 FY25
Revenue
$42M
FY24
PTGX
Protagonist Therapeutics, Inc
Change
144.19
· pre 144.17
· delayed
Pre-market
Oct 30 '26
delayed
Mkt cap
$9.4B
Revenue
$213M
Q2 FY26
Revenue
$46M
FY25
vs
Compare
Pre-market
Oct 30 '26
delayed
TNGX
Tango Therapeutics, Inc.
vs
PTGX
Protagonist Therapeutics, Inc
22.72
pre 22.72
delayed
Price
144.19
pre 144.17
delayed
$3.8B
Mkt cap
$9.4B
Q3 FY25
$54M
Revenue
$213M
Q2 FY26
FY24
$42M
Revenue
$46M
FY25
Change
Change
TNGX
22.72
vs
PTGX
144.19
Pre-market
Oct 30 '26
delayed
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
TNGX, solid
PTGX, dashed